Is Amanta Healthcare a good quality company?

Data is not available for this company.

What is Amanta Healthcare share price return in the past 10 years?

Data is not available for this company

Amanta Healthcare Ltd - Stock Valuation and Financial Performance

Name: Amanta Healthcare
Brand: Amanta Healthcare

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Amanta Healthcare

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray of Amanta Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	9.8%	10.6%	12.7%	10.3%	8.4%	8.3%	8.9%	40%	13.4%	14.2%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	175	203	211	192	185	184	171	225	259	280	185
Sales YoY Gr.	-	15.9%	4.2%	-9.3%	-3.5%	-0.3%	-7.1%	31.6%	14.9%	8.2%	-
Adj EPS ⓘ	0.1	3.4	6.3	3.9	-7.1	-7.5	-8.2	2.1	-1.2	1.5	-5.3
YoY Gr.	-	4100%	88.1%	-38.6%	-282.5%	NA	NA	NA	-156.6%	NA	-
BVPS (₹) ⓘ	34.1	40	46.3	25	17.9	10.9	2.7	24.2	23.4	24.7	16
Adj Net Profit ⓘ	0.3	12.4	23.2	10.3	-19	-20	-22.1	5.7	-3.2	4	-19
Cash Flow from Ops. ⓘ	25.3	39.6	40.2	25.2	32.2	37.9	33.4	63.5	42.6	58.1	-
Debt/CF from Ops. ⓘ	3.7	2.4	2.2	10.1	7.7	6.1	7	3.5	5.1	3.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.4%	8.7%	17.9%	8.2%
Adj EPS ⓘ	38.4%	NA	NA	NA
BVPSⓘ	-3.5%	6.7%	108.9%	5.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	0.2	6.9	11.4	7.3	-33.1	-52	-121.4	15.7	-5.1	6.2	-26.1
Op. Profit Mgn % ⓘ	20.4	20.4	24.4	24.2	22.1	20.3	22.4	23.8	19.8	20.7	NAN
Net Profit Mgn % ⓘ	0.2	6.1	11	5.4	-10.3	-10.9	-12.9	2.5	-1.3	1.4	-10.1
Debt to Equity ⓘ	0.6	0.5	0.4	3.8	5.2	7.9	32.3	3.4	3.4	3.1	-
Working Cap Days ⓘ	173	180	194	238	269	277	296	215	179	162	0
Cash Conv. Cycle ⓘ	65	65	59	91	114	133	160	120	103	97	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials - Amanta Healthcare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-5.3	-
TTM Sales (₹ Cr.)	185	-
BVPS (₹.) ⓘ	16	-
Reserves (₹ Cr.) ⓘ	21	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	35.4
Face Value (₹)	10
Industry PE ⓘ	43

Management X-Ray of Amanta Healthcare:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Amanta Healthcare

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Amanta Healthcare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	174.91	202.75	211.17	191.55	184.87	184.37	171.29	225.44	259.13	280.34
Operating Expenses ⓘ	139.23	161.43	159.91	145.19	143.96	147	132.96	171.81	208.23	222.85
Manufacturing Costs	21.67	20.85	19.87	21.44	21.20	23.38	19.22	72.53	83.03	83.88
Material Costs	65.69	84.62	81.51	68.47	66.89	63.83	49.52	40.35	61.47	70.13
Employee Cost	26.87	28.36	27.77	30	31.34	33.29	34.43	28.13	31.87	32.55
Other Costs ⓘ	24.99	27.60	30.75	25.29	24.52	26.50	29.78	30.80	31.86	36.30
Operating Profit ⓘ	35.68	41.32	51.26	46.35	40.91	37.37	38.34	53.63	50.90	57.49
Operating Profit Margin (%)	20.4%	20.4%	24.3%	24.2%	22.1%	20.3%	22.4%	23.8%	19.6%	20.5%
Other Income ⓘ	1.38	1.61	1.05	2.29	1.69	2.13	1.06	0.83	5.41	1.27
Interest ⓘ	11.90	13.96	12.29	19.81	40.55	38.13	40.13	43.91	35.27	33.64
Depreciation ⓘ	12.44	13.75	14.61	16.44	16.54	16.49	17.02	17.28	18.35	19.73
Exceptional Items ⓘ	0	0	-0.36	0	0	0	0	68.52	0	0
Profit Before Tax ⓘ	12.71	15.22	25.06	12.39	-14.49	-15.12	-17.76	61.79	2.69	5.39
Tax ⓘ	12.16	2.59	1.90	1.06	4.25	3.76	4.08	7.91	4.80	1.76
Profit After Tax	0.55	12.63	23.16	11.33	-18.75	-18.87	-21.83	53.88	-2.11	3.63
PAT Margin (%)	0.3%	6.2%	11.0%	5.9%	-10.1%	-10.2%	-12.7%	23.9%	-0.8%	1.3%
Adjusted EPS (₹)	0.2	3.4	6.3	4.3	-7.0	-7.0	-8.1	20.1	-0.8	1.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	168.64	192.27	215.43	66.52	47.97	29.10	7.26	64.97	62.88	66.29
Share Capital ⓘ	81.31	81.86	81.86	26.63	26.83	26.83	26.83	26.83	26.83	26.83
Reserves ⓘ	87.33	110.42	133.58	39.89	21.14	2.27	-19.56	38.14	36.05	39.46
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	80.42	86.17	75.52	242.93	237.68	226.65	234.65	217.71	211.09	192.14
Long Term Debt	37.77	42.27	32.34	200.36	195.77	192.44	158.08	175.91	175.55	149.03
Short Term Debt	42.66	43.89	43.18	42.57	41.92	34.21	76.56	41.80	35.54	43.12
Trade Payables	29	32.37	34.76	29.28	21.95	17.38	25.30	39	36.21	24.80
Others Liabilities ⓘ	60.31	58.38	63.83	67.25	95.07	114.55	124.90	57.78	64.01	71.96
Total Liabilities ⓘ	338.36	369.19	389.55	405.98	402.67	387.67	392.11	379.46	374.19	355.20
Fixed Assets
Gross Block	321.58	346.97	374.53	395.66	382.75	395.42	399.16	259.35	274.04	279.04
Accumulated Depreciation	86.96	100.71	112.61	128.80	135.90	151.52	157.35	18.02	36.36	50.89
Net Fixed Assetsⓘ	234.62	246.26	261.92	266.86	246.85	243.90	241.81	241.33	237.68	228.15
CWIP ⓘ	2.51	0.09	0.78	1.98	0.23	0	0	0	0	0
Investmentsⓘ	0	0	0	0.10	0.10	0.10	1.50	3.34	3.47	3.72
Inventories	36.81	30.30	29.01	33.84	38.37	39.34	57.24	71.10	68.92	59.45
Trade Receivables	41.17	51.77	61.04	54.09	52.23	52.28	51.48	44.81	53.58	48.17
Cash Equivalents	5.85	6.20	4.56	6.81	13.10	6.22	8.87	9.68	3.87	4.10
Others Assetsⓘ	17.40	34.57	32.23	42.31	51.78	45.83	31.21	9.19	6.67	11.62
Total Assets ⓘ	338.36	369.19	389.55	405.98	402.67	387.67	392.11	379.46	374.19	355.20

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	25.27	39.59	40.20	25.19	32.22	37.88	33.39	63.53	42.58	58.07
PBT ⓘ	12.71	15.22	25.06	12.39	-14.49	-15.12	-17.76	61.79	2.69	5.39
Adjustment ⓘ	25.09	28.02	27.09	36.14	56.41	54.15	58.56	-6.89	53.53	53.66
Changes in Working Capital ⓘ	-9.68	-0.31	-7.36	-16.98	-3.08	-0.99	-12.58	8.73	-7.33	4.97
Tax Paid ⓘ	-2.27	-2.73	-3.31	-1.70	-6.62	-0.16	5.18	-0.10	-6.31	-5.95
Cash Flow From Investing Activity ⓘ	-36.74	-35.99	-21.05	-174.96	-4.67	-10.91	-16.67	-5.38	-6.53	-10.32
Capex	-33.71	-36.55	-23.10	-14.79	-4.63	-10.73	-11.96	-2.81	-6.28	-11.98
Net Investments	0	0	0	0	0	0	0	-2.93	-0.47	1.30
Others ⓘ	-3.03	0.55	2.06	-160.17	-0.04	-0.18	-4.70	0.36	0.22	0.36
Cash Flow From Financing Activityⓘ	11.31	-3.18	-19.64	152.20	-21.22	-35.11	-16.91	-51.99	-42.32	-46.32
Net Proceeds from Shares ⓘ	0	0.55	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-12.36	-14.65	-12.45	-11.56	-15.21	-19.33	-21.05	-41.29	-29.02	-26.26
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	23.67	10.93	-7.19	163.76	-6.01	-15.77	4.14	-10.70	-13.30	-20.07
Net Cash Flow ⓘ	-0.16	0.42	-0.48	2.43	6.33	-8.14	-0.18	6.17	-6.27	1.43

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	0.44	9.33	14.59	9.57	-32.75	-48.98	-120.09	149.18	-3.3	5.63
ROCE (%)	9.83	10.63	12.69	10.33	8.44	8.27	8.91	39.99	13.43	14.19
Asset Turnover Ratio	0.58	0.61	0.59	0.49	0.46	0.47	0.44	0.58	0.69	0.77
PAT to CFO Conversion(x)	45.95	3.13	1.74	2.22	N/A	N/A	N/A	1.18	N/A	16
Working Capital Days
Receivable Days	72	79	92	108	105	103	111	78	69	66
Inventory Days	65	57	48	59	71	77	103	104	99	84
Payable Days	151	132	150	171	140	112	157	291	223	159

Amanta Healthcare Ltd Stock News

Amanta Healthcare Ltd FAQs

What is the share price of Amanta Healthcare?

Company share prices are keep on changing according to the market conditions. The closing price of Amanta Healthcare on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Amanta Healthcare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Amanta Healthcare stood at ₹0.00.

What is the P/E ratio of Amanta Healthcare?

The latest P/E ratio of Amanta Healthcare as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Amanta Healthcare?

The latest P/B ratio of Amanta Healthcare as of 01-Jan-1970 05:30 is 0.00.

What is the 52-week high and low of Amanta Healthcare?

The 52-week high of Amanta Healthcare is ₹0.00 and the 52-week low is ₹0.00.

What is the TTM revenue of Amanta Healthcare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amanta Healthcare is ₹184.9 ( Cr.) .

About Amanta Healthcare Ltd

Marck Biosciences Limited was originally incorporated as Marck Parenterals (India) Limited on December 1994. Subsequently, the name of the company was changed to Marck Biosciences Limited on November 2, 2005. The companyâ€™s registered office is located at 5th Floor, Heritage, Nr. Gujarat Vidhyapith, Off. Ashram Road,Ahmedabad â€“ 380 014, Gujarat, India. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of Fluid Therapy, Injections, Eye Care and Respiratory Care. Its non therapeutic product group comprises of Medical Devices. Medical devices would predominantly be of products such as, Lens cleaning solutions, Eye & wound Irrigation, Eye wash Solution and First aid Solution, for which the company has obtained â€˜CEâ€™ mark.

Business Profile:

The company is a sterile liquid pharmaceutical company headquartered at Ahmedabad, Gujarat, India. Its scope of activities includes formulation and development, manufacturing and marketing in India and approximately 77 countries across 6 continents. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of fluid therapy, injections, eye care and respiratory care. The non therapeutic product group comprises of medical devices. medical devices would predominantly be of products such as, lens cleaning solutions, eye and wound irrigation, eye wash solution and first aid Solution, for which the company has obtained â€˜CEâ€™ mark. Its manufacturing facilities comprises of five Aseptic Blow Fill Seal (ABFS) manufacturing lines and one Aspectic Conventional Plastic Bottle Filling line. It is one of the versatile manufacturer in BFS space, wherein it offer different closure systems, such as nipple head, twist-off, leur-lock & screw types and container fill-volume ranging from 2ml to 1000 ml.

Product Segment: